Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
130M
-
Number of holders
-
246
-
Total 13F shares, excl. options
-
129M
-
Shares change
-
+1.42M
-
Total reported value, excl. options
-
$994M
-
Value change
-
+$12.8M
-
Put/Call ratio
-
0.3
-
Number of buys
-
113
-
Number of sells
-
-133
-
Price
-
$7.72
Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q3 2025
307 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q3 2025.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 246 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 129M shares
of 130M outstanding shares and own 99.42% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (19.3M shares), VANGUARD GROUP INC (13.9M shares), First Light Asset Management, LLC (9.93M shares), Greenhouse Funds LLLP (8.22M shares), MILLENNIUM MANAGEMENT LLC (5.97M shares), STATE STREET CORP (5.02M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (4.45M shares), DIMENSIONAL FUND ADVISORS LP (3.83M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (3.48M shares), and D. E. Shaw & Co., Inc. (3.3M shares).
This table shows the top 246 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.